Brear Paul, De Fusco Claudia, Hadje Georgiou Kathy, Francis-Newton Nicola J, Stubbs Christopher J, Sore Hannah F, Venkitaraman Ashok R, Abell Chris, Spring David R, Hyvönen Marko
Department of Biochemistry , University of Cambridge , 80 Tennis Court Road , Cambridge CB2 1GA , UK . Email:
Department of Chemistry , University of Cambridge , Lensfield Road , Cambridge , CB2 1EW , UK.
Chem Sci. 2016 Nov 1;7(11):6839-6845. doi: 10.1039/c6sc02335e. Epub 2016 Jul 12.
The development of selective inhibitors of protein kinases is challenging because of the significant conservation of the ATP binding site. Here, we describe a new mechanism by which the protein kinase CK2α can be selectively inhibited using features outside the ATP site. We have identified a new binding site for small molecules on CK2α adjacent to the ATP site and behind the αD loop, termed the αD pocket. An elaborated fragment anchored in this site has been linked with a low affinity fragment binding in the ATP site, creating a novel and selective inhibitor (CAM4066) that binds CK2α with a of 320 nM and shows significantly improved selectivity compared to other CK2α inhibitors. CAM4066 shows target engagement in several cell lines and similar potency to clinical trial candidate CX4945. Our data demonstrate that targeting a poorly conserved, cryptic pocket allows inhibition of CK2α a novel mechanism, enabling the development of a new generation of selective CK2α inhibitors.
由于ATP结合位点具有高度保守性,因此开发蛋白激酶的选择性抑制剂具有挑战性。在此,我们描述了一种新机制,利用ATP位点以外的特征可选择性抑制蛋白激酶CK2α。我们在CK2α上鉴定出一个与ATP位点相邻且位于αD环后方的小分子新结合位点,称为αD口袋。一个锚定在该位点的精细片段与一个在ATP位点结合的低亲和力片段相连,产生了一种新型选择性抑制剂(CAM4066),其与CK2α结合的解离常数为320 nM,与其他CK2α抑制剂相比,选择性显著提高。CAM4066在多种细胞系中显示出靶点结合,且效力与临床试验候选药物CX4945相似。我们的数据表明,靶向一个保守性较差的隐蔽口袋可通过一种新机制抑制CK2α,从而能够开发新一代选择性CK2α抑制剂。